DK161800C - Fremgangsmaade til fremstilling af nasale praeparater indeholdende calcitonin - Google Patents

Fremgangsmaade til fremstilling af nasale praeparater indeholdende calcitonin

Info

Publication number
DK161800C
DK161800C DK458183A DK458183A DK161800C DK 161800 C DK161800 C DK 161800C DK 458183 A DK458183 A DK 458183A DK 458183 A DK458183 A DK 458183A DK 161800 C DK161800 C DK 161800C
Authority
DK
Denmark
Prior art keywords
procedure
preparation
preparations containing
nasal preparations
containing calcitonin
Prior art date
Application number
DK458183A
Other languages
Danish (da)
English (en)
Other versions
DK161800B (da
DK458183D0 (da
DK458183A (da
Inventor
Moise Azria
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27449393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK161800(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK458183D0 publication Critical patent/DK458183D0/da
Publication of DK458183A publication Critical patent/DK458183A/da
Priority to DK199001142A priority Critical patent/DK174540B1/da
Publication of DK161800B publication Critical patent/DK161800B/da
Application granted granted Critical
Publication of DK161800C publication Critical patent/DK161800C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK458183A 1982-10-05 1983-10-04 Fremgangsmaade til fremstilling af nasale praeparater indeholdende calcitonin DK161800C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK199001142A DK174540B1 (da) 1982-10-05 1990-05-08 Fremgangsmåde til fremstilling af et flydende farmaceutisk præparat indeholdende calcitonin og beholder indeholdende et sådant præparat

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8228390 1982-10-05
GB8236928 1982-12-30
GB8236928 1982-12-30
GB8320865 1983-08-03
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds
GB8322528 1983-08-22

Publications (4)

Publication Number Publication Date
DK458183D0 DK458183D0 (da) 1983-10-04
DK458183A DK458183A (da) 1984-04-06
DK161800B DK161800B (da) 1991-08-19
DK161800C true DK161800C (da) 1992-01-27

Family

ID=27449393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK458183A DK161800C (da) 1982-10-05 1983-10-04 Fremgangsmaade til fremstilling af nasale praeparater indeholdende calcitonin

Country Status (21)

Country Link
US (2) US5759565A (sv)
JP (1) JPH07103043B2 (sv)
AT (1) AT394947B (sv)
AU (2) AU572800B2 (sv)
CA (1) CA1220138A (sv)
CH (1) CH657779A5 (sv)
DE (1) DE3335086A1 (sv)
DK (1) DK161800C (sv)
FR (1) FR2533826B1 (sv)
HK (1) HK27389A (sv)
HU (1) HU192246B (sv)
IL (1) IL69892A (sv)
IT (1) IT1172324B (sv)
KE (1) KE3848A (sv)
MY (1) MY8700271A (sv)
NL (1) NL192563C (sv)
NZ (1) NZ205846A (sv)
PH (1) PH22725A (sv)
PT (1) PT77443B (sv)
SE (1) SE455671B (sv)
SG (1) SG76388G (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7229966B2 (en) * 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
AU2003299722A1 (en) * 2002-12-17 2004-07-14 Mdrna, Inc. Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
AU2004281532B2 (en) * 2003-10-15 2010-03-18 Pari Pharma Gmbh Liquid preparation containing tobramycin
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20100256060A1 (en) * 2009-04-02 2010-10-07 Unigene Laboratories Inc. Peptide pharmaceuticals for nasal delivery
EP3272769B1 (en) 2012-01-26 2020-06-17 Christopher J. Soares Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use
WO2018045083A1 (en) 2016-09-02 2018-03-08 Soares Christopher J Use of cgrp receptor antagonists in neuroprotection and neurological disorders
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769405A (en) * 1970-04-17 1973-10-30 Armour Pharma Methods for obtaining diuresis
CH539556A (de) * 1971-03-16 1973-07-31 Ciba Geigy Ag Applikator zur dosierten Ausgabe einer Flüssigkeit
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
JPS5625197A (en) * 1979-07-19 1981-03-10 Microbial Chem Res Found Cleomycin and its preparation
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Also Published As

Publication number Publication date
IL69892A (en) 1987-12-31
PT77443B (en) 1986-04-11
NL8303386A (nl) 1984-05-01
FR2533826B1 (fr) 1987-06-12
CH657779A5 (de) 1986-09-30
AU2103588A (en) 1988-12-22
PT77443A (en) 1983-11-01
IT8349105A0 (it) 1983-10-05
FR2533826A1 (fr) 1984-04-06
HUT34121A (en) 1985-02-28
MY8700271A (en) 1987-12-31
DK161800B (da) 1991-08-19
KE3848A (en) 1989-03-31
IL69892A0 (en) 1984-01-31
SG76388G (en) 1989-03-23
HU192246B (en) 1987-05-28
SE8305485D0 (sv) 1983-10-05
CA1220138A (en) 1987-04-07
DE3335086A1 (de) 1984-05-03
DK458183D0 (da) 1983-10-04
SE455671B (sv) 1988-08-01
PH22725A (en) 1988-11-28
SE8305485L (sv) 1984-04-06
HK27389A (en) 1989-04-07
JPH07103043B2 (ja) 1995-11-08
AT394947B (de) 1992-07-27
DE3335086C2 (sv) 1990-09-20
DK458183A (da) 1984-04-06
JPH02262526A (ja) 1990-10-25
IT1172324B (it) 1987-06-18
NL192563B (nl) 1997-06-02
US5759565A (en) 1998-06-02
NL192563C (nl) 1997-10-03
AU572800B2 (en) 1988-05-19
NZ205846A (en) 1987-09-30
ATA349483A (de) 1992-01-15
AU1984983A (en) 1984-04-12
US5733569A (en) 1998-03-31

Similar Documents

Publication Publication Date Title
DK161800C (da) Fremgangsmaade til fremstilling af nasale praeparater indeholdende calcitonin
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
DK157063C (da) Fremgangsmaade til fremstilling af unilamellaere liposomer
DK158930C (da) Fremgangsmaade til fremstilling af antifungalt farmaceutisk praeparat til ekstern anvendelse
DK159824C (da) Analogifremgangsmaade til fremstilling af succinylferroproteiner
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK427281A (da) Fremgangsmaade til fremstilling af terapeutiske praeparater
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK508983A (da) Fremgangsmaade til fremstilling af analgetisk virksomme peptidforbindelser
DK340483A (da) Fremgangsmaade til fremstilling af fluoralkylerede carbapenemderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK185683D0 (da) Fremgangsmade til fremstilling af pleuromutilinderivater
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK296383A (da) Fremgangsmaade til fremstilling af fenaetylaminer
DK228381A (da) Fremgangsmaade til fremstilling af antidiarretiske farmaceutiske praeparater
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
DK62283D0 (da) Fremgangsmade til fremstilling af peptidergotalkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK152051C (da) Fremgangsmaade til fremstilling af krystallinsk natriumcefoperazon
DK519183D0 (da) Fremgangsmade til fremstilling af oxazolinoazetidinon-forbindelser

Legal Events

Date Code Title Description
PUP Patent expired